Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism.

BACKGROUND Differentiating patients with primary aldosteronism caused by aldosterone-producing adenomas (APAs) from those with bilateral adrenal hyperplasia (BAH), which is essential for choice of therapeutic intervention, relies on adrenal venous sampling (AVS)-based measurements of aldosterone and cortisol. We assessed the utility of LC-MS/MS-based steroid profiling to stratify patients with primary aldosteronism. METHODS Fifteen adrenal steroids were measured by LC-MS/MS in peripheral and adrenal venous plasma from AVS studies for 216 patients with primary aldosteronism at 3 tertiary referral centers. Ninety patients were diagnosed with BAH and 126 with APAs on the basis of immunoassay-derived adrenal venous aldosterone lateralization ratios. RESULTS Among 119 patients confirmed to have APAs at follow-up, LC-MS/MS-derived lateralization ratios of aldosterone normalized to cortisol, dehydroepiandrosterone, and androstenedione were all higher (P < 0.0001) than immunoassay-derived ratios. The hybrid steroids, 18-oxocortisol and 18-hydroxycortisol, also showed lateralized secretion in 76% and 35% of patients with APAs. Adrenal venous concentrations of glucocorticoids and androgens were bilaterally higher in patients with BAH than in those with APAs. Consequently, peripheral plasma concentrations of 18-oxocortisol were 8.5-fold higher, whereas concentrations of cortisol, corticosterone, and dehydroepiandrosterone were lower in patients with APAs than in those with BAH. Correct classification of 80% of cases of APAs vs BAH was thereby possible by use of a combination of steroids in peripheral plasma. CONCLUSIONS LC-MS/MS-based steroid profiling during AVS achieves higher aldosterone lateralization ratios in patients with APAs than immunoassay. LC-MS/MS also enables multiple measures for discriminating unilateral from bilateral aldosterone excess, with potential use of peripheral plasma for subtype classification.

[1]  S. Gillingwater,et al.  Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays , 2008, Annals of clinical biochemistry.

[2]  Gabriele Siegert,et al.  An LC–MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  S. Ito,et al.  18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  F. Beuschlein,et al.  Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. , 2011, European journal of endocrinology.

[5]  Ilaria Belluomo,et al.  Serum steroid profiling by isotopic dilution-liquid chromatography–mass spectrometry: Comparison with current immunoassays and reference intervals in healthy adults , 2011, Steroids.

[6]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  C. Gomez-Sanchez,et al.  Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. , 1984, The Journal of clinical endocrinology and metabolism.

[8]  M. Quinkler,et al.  Treatment of primary aldosteronism. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[9]  S. Matthew,et al.  Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases , 2011, Hormones & cancer.

[10]  Yasuhiro Nakamura,et al.  Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation. , 2013, The Journal of clinical endocrinology and metabolism.

[11]  P. Milliez,et al.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.

[12]  M. Stowasser,et al.  Primary Aldosteronism , 2014, Springer New York.

[13]  J. Blumenfeld,et al.  The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  P. Plouin,et al.  Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study , 2013, Hypertension.

[15]  D. Schteingart,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2012 .

[16]  E. Cavalier,et al.  Laboratory challenges in primary aldosteronism screening and diagnosis. , 2015, Clinical biochemistry.

[17]  Alan L Rockwood,et al.  Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS/MS and comparison with commercial immunoassays. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  R. Gordon,et al.  ALDOSTERONE‐PRODUCING ADENOMAS RESPONSIVE TO ANGIOTENSIN POSE PROBLEMS IN DIAGNOSIS , 1987, Clinical and experimental pharmacology & physiology.

[19]  Michael R. Kennedy,et al.  Liquid chromatography–tandem mass spectrometry analysis of human adrenal vein corticosteroids before and after adrenocorticotropic hormone stimulation , 2012, Clinical endocrinology.

[20]  M. Stowasser,et al.  Does concomitant autonomous adrenal cortisol overproduction have the potential to confound the interpretation of adrenal venous sampling in primary aldosteronism? , 2015, Clinical endocrinology.

[21]  S. Ito,et al.  Measurement of Peripheral Plasma 18-Oxocortisol Can Discriminate Unilateral Adenoma From Bilateral Diseases in Patients With Primary Aldosteronism , 2015, Hypertension.

[22]  C. Gomez-Sanchez,et al.  18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  J. Jonklaas,et al.  Use of steroid profiles in determining the cause of adrenal insufficiency , 2007, Steroids.

[24]  J. Connell,et al.  Plasma steroid profiling and response to trophins to illustrate intra-adrenal dynamics. , 2015, The Journal of endocrinology.

[25]  M. Stowasser,et al.  Primary aldosteronism—careful investigation is essential and rewarding , 2004, Molecular and Cellular Endocrinology.

[26]  D. Blondin,et al.  Indication and Technical Aspects of Adrenal Blood Sampling , 2014, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[27]  R. Holle,et al.  Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry , 2012, Hypertension.

[28]  J. Connell,et al.  A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. , 2008, Endocrine reviews.

[29]  U. Stenman,et al.  Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  Graeme Eisenhofer,et al.  Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas , 2016, Hypertension.

[31]  C. Shackleton.  Clinical steroid mass spectrometry: A 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosis , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  Gerald Antoch,et al.  Plasma Metanephrine for Assessing the Selectivity of Adrenal Venous Sampling , 2013, Hypertension.

[33]  B. Keevil,et al.  Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  Stephen J. Bruce,et al.  Discrepancy between radioimmunoassay and high performance liquid chromatography tandem-mass spectrometry for the analysis of androstenedione. , 2014, Analytical biochemistry.

[35]  R. Golfieri,et al.  Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas. , 2015, The Journal of clinical endocrinology and metabolism.

[36]  P. Plouin,et al.  Influence of Diagnostic Criteria on the Interpretation of Adrenal Vein Sampling , 2015, Hypertension.

[37]  Daniel T Holmes,et al.  Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid–liquid extraction method for the ABSCIEX API-5000 mass spectrometry system , 2012, Journal of Clinical Pathology.

[38]  E. Diamandis,et al.  A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. , 2015, Clinical chemistry.

[39]  张炜,et al.  Primary Aldosteronism , 2014, Springer New York.

[40]  M. Anlauf,et al.  Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism. , 2011, European journal of endocrinology.

[41]  K. Martin.  Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism , 2013 .